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Background: Hypusine modification of the eukaryotic initiation factor 5A (eIF-5A) represents a conserved post-transla-
tional modification that regulates translation.
Results: Deletion of hypusine modification enzymes exerts strong phenotypes. eIF-5A2-deleted animals are viable and fertile.
Conclusion: Both enzymatic steps of hypusine modification are essential for mammalian homeostasis, whereas the cancer-
related isoform eIF-5A2 is dispensable.
Significance: eIF-5A2 might represent a safe therapeutic target.
Hypusine modification of the eukaryotic initiation factor 5A
(eIF-5A) is emerging as a crucial regulator in cancer, infections,
and inflammation. Although its contribution in translational
regulation of proline repeat-rich proteins has been sufficiently
demonstrated, its biological role in higher eukaryotes remains
poorly understood. To establish the hypusine modification sys-
tem as a novel platform for therapeutic strategies, we aimed to
investigate its functional relevance in mammals by generating
and using a range of new knock-out mouse models for the
hypusine-modifying enzymes deoxyhypusine synthase and
deoxyhypusine hydroxylase as well as for the cancer-related iso-
form eIF-5A2. We discovered that homozygous depletion of
deoxyhypusine synthase and/or deoxyhypusine hydroxylase
causes lethality in adult mice with different penetrance com-
pared with haploinsufficiency. Network-based bioinformatic
analysis of proline repeat-rich proteins, which are putative
eIF-5A targets, revealed that these proteins are organized
in highly connected protein-protein interaction networks.
Hypusine-dependent translational control of essential proteins
(hubs) and protein complexes inside these networks might
explain the lethal phenotype observed after deletion of
hypusine-modifying enzymes. Remarkably, our results also
demonstrate that the cancer-associated isoform eIF-5A2 is dis-
pensable for normal development and viability. Together, our
results provide the first genetic evidence that the hypusinemod-
ification in eIF-5A is crucial for homeostasis inmammals.More-
over, these findings highlight functional diversity of the
hypusine system compared with lower eukaryotes and indicate
eIF-5A2 as a valuable and safe target for therapeutic interven-
tion in cancer.
Control of translational processes is essential to maintain
cellular function and organismal integrity (1). In addition to the
important role in normal physiology, there is accumulating evi-
dence that alterations in the translation machinery (e.g. dereg-
ulated translation factors) lead to changes in protein biosynthe-
sis and the development or progression of various diseases like
cancer and viral infections (2, 3). Given that translation factors
are frequently regulated by post-translational modifications,
which are mediated by enzymes, those modifications can be
harnessed therapeutically (4).
In this context, the eukaryotic initiation factor 5A (eIF-5A)
represents a particularly interesting target for therapeutic
intervention because it carries a highly specific post-transla-
tional modification, the unusual amino acid hypusine, which is
unique in this protein (5, 6). The biosynthesis of hypusine is
catalyzed from lysine in a two-step enzymatic reaction. First,
the deoxyhypusine synthase (DHS)3 transfers a 4-aminobutyl
moiety of spermidine to the -amino group of Lys50 to form a
deoxyhypusine-containing intermediate. Second, the deoxyhy-
pusine hydroxylase (DOHH) catalyzes the hydroxylation of
the deoxyhypusine residue to generate hypusine-containing
eIF-5A (Fig. 1A). Hypusine ismandatory for eIF-5A activity and
function (7, 8), and only hypusinated eIF-5Awas shown to con-
trol translation elongation as well as the nuclear export of spe-
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cific mRNAs (9, 10). Moreover, recent studies linked eIF-5A to
the translational control of proteins containing consecutive
proline residues (11).
Like other translation factors, eIF-5A and its modifying
enzymes, DHS and DOHH, are highly conserved in eu-
karyotes as well as archaea. Prokaryotes express an orthologous
factor, the elongation factor P (12). Although elongation factor
P is not hypusine-modified, it is activated by a similar modifi-
cation (lysinylation) at a comparable amino acid position
(Lys34) and promotes translation of polyproline motifs in the
same way as eIF-5A (13–15). Based on work in yeast, it seems
that eIF-5A and its hypusinemodification are essential in lower
eukaryotes. However, a fundamental unanswered question is
whether the hypusine axis is crucial for viability of mammals.
The observation that eIF-5A is also involved in diseases
like cancer, infections, and diabetes highlights eIF-5A and
particularly its hypusine modification as an attractive target
for the development of new therapeutic strategies. Up-regu-
lation of the eIF-5A1 isoform and the hypusine-forming
enzymes can be found in many types of tumors, and inhibi-
tion of hypusination by siRNA or small molecules showed
anti-proliferative effects in numerous tumor entities (16,
17). However, the hypusine system may have pleiotropic
functions, as seen for the tumor suppressor activity of eIF-
5A1 and DHS in lymphoma development (18). Moreover,
perturbation of hypusination also preserves islet function in
diabetes and blocks the replication cycle of HIV by affecting
the export of specific mRNAs (19). Intriguingly, many can-
cers and tumor cell lines display elevated levels of eIF-5A2,
an isoform of eIF-5A that shows no expression in normal
tissue except brain and testis (20). In addition to its onco-
genic activity (21, 22), eIF-5A2 was demonstrated to pro-
mote invasion and metastasis, and overexpression correlates
with worse prognosis in various cancers (23, 24).
Together, a growing body of research now indicates that the
enzymes of the hypusine system fulfill certain criteria for being a
potential therapeutic target (25, 26), and consequently, lead sub-
stanceshavebeendeveloped (27, 28).However, akeyquestion that
still needs to be addressed before the hypusine system can be con-
sidered a novel target for therapies is to understand its function in
mammalian homeostasis. In this regard, development of mouse
models formanipulationof thehypusine systemcouldprovide the
most valuable tool for addressing this question (29). Based on that
consideration,wegeneratedandcharacterized conditional knock-
outmousemodels forDhs,Dohh, and eIF-5A2 that allowed either
thegeneral inhibitionofbothstepsofhypusinemodificationor the
selective depletion of the cancer-associated eIF-5A2 isoform in a
particular temporal setting.
Experimental Procedures
Animal Studies—All animal experimental procedures were
approved by the responsible Hamburg state authority accord-
ing to German animal protection law.Mice weremaintained in
specific pathogen-free conditions at the University Medical
Center Hamburg-Eppendorf animal facilities.
Generation of Conditional Knock-out Mice—Embryonic
stem cell clones derived from C57BL/6N mice for the
conditional knock-out of the Dhs (clones EPD0628_1_B06,
EPD0628_1_C06, and EPD0628_1_F05) or eIF-5A2 (clone
HEPD0734_3_A07) gene were obtained from the International
Knock-out Mouse Consortium (30) and were verified by
Southern blot and/or long range PCR. Clones were thawed,
injected into E3.5 blastocysts of C57BL/6J mice, and trans-
ferred into the uterine horns of foster mothers. Male chime-
ric offspring were mated to C57BL/6J females and the result-
ing offspring analyzed for transmission of the targeted allele.
Transgene-positive male offspring was mated to Flp-deleter
(B6;SJL-Tg(ACTFLPe)9205Dym/J (31)) to remove the selec-
tion cassette. Resulting offspring were selected for the floxed
allele, hereafter referred to with a superscript “p.” Wild type
alleles are indicated with a superscript “.” To generate a
complete knock-out of Dhs or eIF-5A2, CMV-Cre-deleter
(32) were mated to mice of the Dhs/p or eIF-5A2/p geno-
types. After Cre-mediated deletion, the knock-out alleles are
indicated with a superscript “.” Mice of the resulting
Dhs/ or eIF-5A2/ genotypeswere furthermated to individ-
uals of the same genotype. To enable a 4-OHT-inducible knock-
out of Dhs or Dohh, mice of the B6.Cg-Tg(CAG-cre/-
Esr1)5Amc/J113 strain (The Jackson Laboratory, Bar Harbor,
ME) were mated to mice of the Dhs/p or Dohh/p genotype.
Mice of the resulting Dhs/p;CAG-cre/Esr1 or Dohh/p;
CAG-cre/Esr1 genotypes were furthermated to individuals of
the same genotype (Fig. 1B). Tamoxifen (4-OHT)-inducible
knock-out was induced by administering 4-OHT-containing
feed (0.4 g/kg, LASvendi, Soest, Germany) for up to 3 weeks.
Mice weremonitored regularly andweighed at least every week
(Fig. 1C).
Southern Blot Analysis—Southern blot was carried out as
described previously (33).
Long Range PCR—Genomic DNA was isolated using QI-
Aamp DNA blood mini kit (Qiagen, Venlo, NL) according to
manufacturer’s instructions. Long range PCR was performed
using oligonucleotides listed in Table 1 and Long PCR Enzyme
Mix (Thermo Fisher Scientific,Waltham,MA). PCRswere per-
formed at 94 °C for 90 s, followed by 10 cycles of 95 °C for 15 s,
54 °C for 30 s, and 68 °C for 7min and 25 cycles of 95 °C for 15 s,
54 °C for 30 s, and 68 °C for 7 min 5 s/cycle and final elonga-
tion at 68 °C for 10 min.
Genotyping Using Genomic DNA from Tail Clippings, Organs,
Embryos, or Culture Cells—Samples were digested overnight at
55 °C using proteinase K (Thermo Fisher Scientific, Waltham,
MA) according to the manufacturer’s instructions. PCR analy-
ses of genomic DNA were performed using DreamTaq Green
PCRMasterMix (Thermo Fisher Scientific,Waltham,MA) and
2 l of lysate in a total volume of 20 l. The oligonucleotide
sequences are listed in Table 1.
Quantitative PCR—RNA was isolated from cell or tissues
using TriFast (Peqlab, Erlangen, Germany) according to the
manufacturer’s instructions. cDNA was prepared by reverse
transcription of 1 g of total RNA using random hexamer
primer and Moloney murine leukemia virus reverse transcrip-
tase (Thermo Fisher Scientific, Waltham, MA). Quantitative
real time PCR for Dhs, Dohh, eIF-5A1, and eIF-5A2 was per-
formed in a 7500 Fast Real Time PCR System (Life Technolo-
gies, Inc.) using the oligonucleotides or QuantiTect primermix
(Qiagen, Venlo, Netherlands) listed in Table 1 and Platinum
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SYBR Green qPCR SuperMix-UDG (Life Technologies, Inc.).
PCRs were performed at 95 °C for 3 min, followed by 40 cycles
of 95 °C for 15 s and 60 °C for 30 s. PCRs were conducted in
triplicate and normalized against 18S rRNA orGapdh as refer-
ence gene using the 2CT method (34).
Expression of eIF-5A2 in normal mouse tissue was examined
using the Tissue Scan qPCR Array MDRT101 (OriGene Tech-
nologies, Rockville, MD). Values were normalized to the
expression of the housekeeping gene Gapdh and depicted as
fold change based on the bone marrow.
One- and Two-dimensional Western Blot Analysis—One-
and two-dimensionalWestern blot analyses were carried out as
described before (16, 33) using anti-eIF-5A1 (Novus Biologi-
cals, Littleton, CO) and anti-eIF-5A2 (Abcam,Cambridge,UK).
FIGURE 1. Overview of the hypusine modification and experimental design to study its role in mammals. A, schematic representation of hypusine
synthesis in eIF-5A catalyzed by the DHS and DOHH enzymes. Red numbers in parentheses indicate the knock-out strategy for the respective gene as outlined
in B. Hyp, hypusine; Dhp, deoxyhypusine. B, conditional knock-out strategy using two Cre-deleter mouse strains for either an early constitutive (1) and/or a
4-OHT-inducible (2) knock-out of the respective gene. Cre mouse strains are as follows: (1) B6.C-Tg(CMV-cre)1Cgn/J; (2) B6.Cg-Tg(CAG-cre/Esr1*)5Amc/
J113. C, time schedule for the 4-OHT-inducible knock-out (2) of the genes outlined in B.
TABLE 1
Oligonucleotides used in this study
Application Oligonucleotide Sequence/Qiagen QuantiTect number
Long range PCR 3 universal CAC ACC TCC CCC TGA ACC TGA AAC
3 Dhs gene-specific CAG GTT CTA TCG ATT CCA GTG TCC G
3 Dhs gene-specific GTG GCC ACG GCT ACG AAG TGC TAG
3 eIF-5A2 gene-specific GAT GAC TGC TGT GTG GAA TAG TAT CAT CTG
3 eIF-5A2 gene-specific GAG GAG GAC CAT GAG ATG GTG AGG ACA TG
Genotyping Dhs-forward CCT CTG CCC TCT CAC AGA CCT GCG
Dhs-5-arm AGA GCG CCC AGG TCC AAG GCT ACG
Dhs-3-arm AGC GTT AAG CTC CTC CTA CAA AGC
Dhs-rev ACC ATC CGC AGG AGA CCA CAC CTA
eIF-5A2-5-arm AGC CGA GAT GCT TGG GAA CTG GAG G
eIF-5A2-3-arm TGG AGT ATA CTT TGC CAT TCA GGC C
eIF-5A2-reverse AAG GCC AGC CTG AGA CCT AT
Quantitative PCR 18S-rRNA QT01036875
Dhs QT02529093
Dohh QT00163268
eIF-5A1 QT01757861
eIF-5A2 QT00148225
Dhs del forward TTC AAC CGC GGC GTA GAT TA
Dhs del reverse TCT GCT CCA TTC CTC ATG GC
Manipulation of HypusineModification System inMammals
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Generation and Culture of Mouse Embryonic Fibroblasts
(MEFs)—MEFswere isolated fromDhs/Dhs/p;CAG-cre/
Esr1 and Dhsp/p  Dhs/p;CAG-cre/Esr1 matings as
described previously (33). The cells were cultured in DMEM
(all cell culture media and additives were from Invitrogen) sup-
plemented with 10% fetal bovine serum, 50 units/ml penicillin,
50 g/ml streptomycin, 25 M -mercaptoethanol, and 4 mM
L-glutamine (37 °C, 5% CO2, humidified atmosphere). For
inducible knock-out experiments, 106 cells were seeded on a
10-cm culture dish, maintained at subconfluence, and treated
with 100 nM 4-OHT for up to 10 days (Sigma) or 50MGC7 for
2 days (Biosearch Tech., Novato, CA).
Morphological and Histopathological Analysis of Mouse
Tissue—Micewere transcardially perfusedwith amixture of 4%
paraformaldehyde (and 1% glutaraldehyde) in 0.1 MPB buffer at
pH 7.4 for tissue preparation, and bone marrow was morpho-
logically analyzed as described before (33). Briefly, after post-
fixation overnight at 4 °C, tibiae were decalcified for 4 days in
10% (w/v) EDTA in PBS and cut in 150-m sagittal sections
with a vibratome. The sections were then postfixed in 1% (v/v)
OsO4, dehydrated, and embedded in Epon. Semi-thin sections
(0.5m)were labeledwithmethylene blue and examined under
the light microscope (Zeiss). Other tissues were processed to
paraffin blocks using an ASP300S dehydration machine (Leica,
Wetzlar, Germany) and an EG1160 tissue-embedding system
(Leica, Wetzlar, Germany). Paraffin blocks were cut into 4-m
sections, which were stained with hematoxylin and eosin or
with Turnbull’s blue reagents following standard laboratory
procedures.
Immunohistochemistry—For immunohistochemical staining
the Ventana Benchmark XT machine (Ventana, Tucson, AZ)
was used. Briefly, deparaffinated sections were boiled for
30–60min in 10mMcitrate buffer, pH 6.0, for antigen retrieval.
Primary antibodies were diluted in 5% goat serum (Dianova
Immunodiagnostics, Hamburg, Germany), 45% Tris-buffered
saline, pH 7.6 (TBS), and 0.1%Triton X-100 in antibody diluent
solution (Zytomed, Berlin, Germany). Sections were then incu-
bated with primary antibody against anti-Ki67 for proliferating
cells (1:250; Abcam, Cambridge, UK) and anti-caspase-3 for
apoptotic cells (1:1000; R&D Systems, Wiesbaden, Germany)
for 1 h. Anti-rabbit histofine Simple Stain MAX PO universal
immunoperoxidase polymers (Nichirei Biosciences, Wedel,
Germany) were used as secondary antibodies. Detection of sec-
ondary antibodies and counterstaining was performed with an
ultraview universal DAB detection kit from Ventana according
to the standard settings of the machine. All sections were cov-
erslipped using TissueTek glove mounting media (Sakura
Finetek, Staufen, Germany) and dried in an incubator at 60 °C.
Pictures were taken using a light microscope (Axioskop 40,
Zeiss, Jena, Germany or Olympus BH-2, Hamburg, Germany)
equipped with a digital camera (AxioCam ICc3 Zeiss, Jena
Germany).
eIF-5A1 Immunofluorescence of Immortalized 3T3 Dohh
Knock-out Cells or Primary Dhs Knock-out MEFs—Knock-out
of Dohh or Dhs was induced with 100 nM 4-OHT for 7 days in
3T3Dohhp/p;CAG-cre/Esr1 (33) or inMEFsDhsp/p;CAG-cre/
Esr1, respectively. The cells were then seeded onto poly-L-
lysine (Sigma)-coated 10-mm diameter round glass coverslips
in 24-well plates and left to adhere for 1 more day in the pres-
ence or absence of 4-OHT. After washing with PBS, the cells
were fixedwith 3% (w/v) paraformaldehyde in PBS for 20min at
room temperature. After washing, residual paraformaldehyde
was quenched with 50 mM NH4Cl in PBS for 10 min. For per-
meabilization, the cells were treated for 5 min with 0.1% (v/v)
Triton X-100 in PBS, and then the samples were blocked with
0.5% (w/v) BSA in PBS for 30 min. Immunostaining was per-
formed with mouse anti-eIF-5A1 (clone 26/eIF-5a; BD Biosci-
ences) and Alexa Fluor 488-labeled goat anti-mouse antibody
(Life Technologies, Inc.). Cell nuclei were stained withHoechst
33342 (Life Technologies, Inc.). Images were taken as single
confocal sections of 1 m using a Nikon C2 confocal laser
scanning microscope (Nikon Instruments, Tokyo, Japan). For
image acquisition and preparation, Nikon NIS Elements soft-
ware andAdobe Photoshop CS4 (Adobe Systems Inc., San Jose,
CA) were used.
Construction and Analysis of Protein-Protein Interaction
Networks—For the construction of protein-protein interaction
(PPI) networks for PPP (Pro-Pro-Pro)- and PPG (Pro-Pro-Gly)-
rich proteins, genes with 1 PPP unit and 1 PPG unit were
extracted as described byMandal et al. (35). The number of PPP
and PPG units were defined by the whole number of consecu-
tive prolines divided by 3, as described recently (35). That
means that 3–5 consecutive prolines were all counted as 1 PPP
unit and 6–8 consecutive prolines as 2 PPP units and so on.
STRING database version 10.0 was used as resource for con-
traction of PPI networks (36). PPI networks were visualized and
analyzed using the software platform Cytoscape 3.2.1 with the
pluginsMCODE for cluster analysis and BinGO for gene ontol-
ogy analysis of protein clusters (37–39). Global network topo-
logical analysis, including clustering coefficients, average num-
ber of neighbors (degree), and network heterogeneity as well as
local network analysis using betweenness centrality value cal-
culation were carried out with NetworkAnalyzer and the Cyto-
scape plugin CytoNCA (40, 41). The edges in all PPI networks
were treated as undirected. Clustering coefficient for a network
is the average of the clustering coefficient over all nodes and
quantifies the local interconnectivity of a network.Node degree
is the number of edges linked to a node. Network heterogeneity
reflects tendency of a network to contain highly connected
nodes (hubs). Betweenness centrality is a measure of the frac-
tion of shortest paths passing through a node in the network,
and nodes with higher betweenness aremore globally central in
the network (42).
Statistics—For statistical analyses GraphPad software (Graph-
Pad Software, La Jolla, CA) was used. The statistical tests used
in each analysis are stated in the corresponding figure legends.
Results
Dhs Is Crucial for Embryonic Development asWell as for Via-
bility in Adult Mice—To study the biological relevance and
functional requirement of the hypusinemodification in embry-
onic development (43, 44) and for viability, we used a recently
described conditional knock-out strain for Dohh (33) and
established a new conditional knock-out mouse model for Dhs
(B6.Dhpstm2a(EUCOMM)Wtsi). For the generation of the latter
strain, embryonic stem cell clones were obtained from the
Manipulation of HypusineModification System inMammals
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International Knock-out Mouse Consortium (30). Detailed
explanation for the Dhs gene targeting strategy that leads to
deletion of exons two to seven resulting in a nonfunctional
truncated Dhs is depicted in Fig. 2A. Information about the
genotyping procedure is provided in Fig. 2B. For Cre-mediated
knock-outs, we intercrossed B6.Dhpstm2a(EUCOMM)Wtsi to two
different Cre-deleter strains allowing us to analyze how Dhs
impairs either embryonic development or affects the viability of
an adult organism after 4-OHT-mediated Cre induction (Fig. 1,
B and C). After removal of the selection cassette, we induced a
general knock-out using the CMV-Cre mouse model (Fig. 1B)
(32). The loss of Dhs leads to embryonic lethality in a pure
C57BL/6 background as we could not detect any homozygous
Dhs/ offspring in our crossings (Fig. 3A). This observation is
well in linewith data obtained in amixed backgroundpublished
by others (43, 44). Heterozygous Dhs/ animals were viable
and did not show any obvious phenotype. Intriguingly, whenwe
investigatedmRNA levels in several organs ofDhs/mice, we
detected a significant up-regulation of Dhs as well as Dohh and
eIF-5A1 comparedwithwild typeDhs/ animals (Fig. 3,B–D).
Moreover, eIF-5A1 protein levels were also elevated (Fig. 3, E
and F), suggesting a compensatory feedback mechanism and
up-regulation of the hypusine system in a Dhs-compromised
setting protecting against the loss of DHS activity. We next
asked whether heterozygous deletion of Dhs results in a
reduced hypusine modification level in eIF-5A1. Two-dimen-
sional Western blots revealed an accumulation of two addi-
tional eIF-5A1 spots in tissue from Dhs/ mice (Fig. 3G).
According to previous data (33, 45), these spots represent the
unhypusinated (Fig. 3G, red arrow) and the more acidic unhy-
pusinated and acetylated form of eIF-5A1 (Fig. 3G, blue arrow).
Nevertheless, high amounts of hypusinated and therefore func-
tional eIF-5A1 remained detectable (Fig. 3G, black arrow),
explaining the normal phenotype ofDhs heterozygous animals.
These observations indicate that under physiological condi-
tions a reduced pool of fully modified eIF-5A1 is sufficient to
support normal cellular function. As previous studies proposed
a pro-apoptotic function for unhypusinated eIF-5A1 (46), our
FIGURE 2. Generation of a conditional Dhs knock-out mouse strain using ES-cell clones harboring a targeted mutation of the Dhs gene. A, schematic
representation of the strategy for achieving a knock-out of the Dhs gene. The seven exons designed for deletion are depicted in a lighter color. Blue arrows
indicate regionsencodingaminoacids that areessential forbindingofNAD;greenarrows indicate regionsessential forbindingof spermidine (86). The targeted
mutation of theDhsgene consists of a lacZ-reporter cassette (SA, splice acceptor; IRES, internal ribosome entry site; lacZ,-galactosidase gene; pA,polyadenyl-
ation signal), a neomycin-selection cassette (PAct, eukaryotic -actin promotor; neo
R, neomycin resistance gene), and three loxP and two FRT sites. B,
genotyping strategy for Cre-mediated knock-out of the Dhs gene. Animals harboring the floxed Dhs genes were mated to Cre-deleter mice (B6.C-Tg(CMV-
cre)1Cgn/J strain or B6.Cg-Tg(CAG-cre/Esr1)5Amc/J113 strain plus oral 4-OHT administration. Usage of three oligonucleotides (Dhs-3-arm, Dhs-for, and
Dhs-rev) allows simultaneous detection of all possible alleles (, p, and), including the deleted allele (), which is achieved by Cre-mediated recombination.
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results further suggest that accumulation of low levels of unhy-
pusinated eIF-5A1 does not affect embryonic development and
viability.
First Step ofHypusineModification Is Essential forViability—
Given the crucial function of Dhs in embryonic development,
we next investigatedwhetherDhs is also essential for viability of
an adult organism. For this reason, we utilized a 4-OHT-induc-
ible conditional CAG/Cre-Esr1mouse strain (Fig. 1, B andC),
allowing us to induce a general knock-out ofDhs inmost tissues
(47). First, we employed Dhs/ and Dhsp/p mouse embryonic
fibroblasts to investigate the functionality of the Cre-mediated
Dhs knock-out in vitro. The analysis outlined in Fig. 3H
revealed a clear reduction of wild type Dhs transcript after
4-OHT treatment and impaired hypusination of eIF-5A1 in
those cells (Fig. 3I), showing loss of DHS activity. Next, we
inducedDhs deletion in 5–7-week-oldmice using 4-OHT-con-
FIGURE 3.Homozygous deletion ofDhs is embryonically lethal in mice, whereas heterozygousDhs knock-out animals are viable and show compen-
satory up-regulation of the hypusine system. A, representative litter size of the indicated breeding. Note that no Dhs/ pups were born after Dhs/ 
Dhs/ breeding. B–D,mRNA levels ofDhs,Dohh, and eIF-5A1 in different organs of wild type or heterozygousmice as assessed by quantitative real time PCR.
Expression values were plotted relative to the expression of the housekeeping gene 18S rRNA. E and F, expression of eIF-5A1 protein in different organs using
Western blot. Protein expression was quantified relative to the loading control -tubulin using the Odyssey Infrared Imaging System. G, two-dimensional
Western blot detecting different eIF-5A1 forms in the outlined organs. H and I, analysis of MEFs isolated from Dhs-deficient Dhsp/ and Dhsp/p-CAG-cre/Esr1
mice as well as wild typeDhs/; CAG-cre/Esr1 animals after 4-OHT treatment in vitro.H,mRNA expression status ofDhs after 100 nM 4-OHT treatment at the
indicated time points relative to the housekeeping gene 18S as assessed by quantitative real time PCR. I, two-dimensional Western blot for eIF-5A1 after
treatment with 4-OHT (100 nM; 8 days) or incubation with 50 M GC7 (2 days). Significances were calculated using the unpaired t test and marked with an
asterisk if significant (***, p	 0.001; **, p	 0.01; *, p	 0.05). , wild type allele; , deleted allele. Colored arrows in the representative blots correspond to the
different eIF-5A1 forms as outlined in the schematic plot on the left: black fully hypusinated Lys50, pH 5.2; red unmodified Lys50, pH 5.1; blue unmodified
Lys50 plus acetylated Lys47, pH 5.0. qPCR, quantitative PCR. n.d., not detectable.
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taining feed. Intriguingly, after 4-OHT administration Dhsp/
animals behaved similarly to Dhs/ mice, whereas the body
weight of Dhsp/p animals drastically decreased (Fig. 4A), and
mice died or had to be euthanized due to a wasting syndrome
(weight loss20%) 5–14 days after induction of the knock-out
(median 12 days; Fig. 4B). Notably, theDhsp/p mice expressed a
truncated form of Dhs suggesting a successful knock-out (Fig.
4D) that leads to the accumulation of the unhypusinated eIF-
5A1 precursor protein as shown in heart and spleen by two-
dimensional Western blot (Fig. 4C). However, those animals
also displayed a significant up-regulation of the hypusine sys-
tem in different organs at a terminal stage involving a remark-
able increase in mRNA of Dhs, Dohh, and eIF-5A1 (Fig. 4D),
compared with their normal Dhs/ counterparts, as well as a
detectable level of hypusinated eIF-5A1 (Fig. 4C). This argues
for a partial knock-out in organs of Dhsp/p animals due to an
incomplete mosaic-like expression of the Cre recombinase in
CAG/Cre-Esr1 mice, as is known for this particular Cre-del-
eter strain (47). Furthermore, this implicates the activation of a
compensatory positive feedback mechanism in the remaining
wild type cells, similarly as observed in heterozygous Dhs/
mice (Fig. 3, B–F), to keep the hypusinemodification in a range
that allows viability.
Deletion ofDhsAffects BoneMarrowand SpleenCellularity—
To identify putative morphological abnormalities accounting
for the observed strong lethal phenotype associated with the
loss ofDhs, we performed comprehensive histological analyses.
Although these analyses did not point to a single recurrent tis-
sue defect causing lethality, histopathological examination
unveiled gross changes in various organs of Dhsp/p animals
compared with their normal wild type Dhs/ counterparts.
The hematopoietic system seemed to be severely affected
because the bonemarrow and the spleen showed reduced over-
all cellularity in Dhsp/p animals. As shown in Fig. 4E, this was
FIGURE 4. Loss ofDhs confers lethality in adultmice and affects organ integrity. A–E, analysis of adultDhs/,Dhsp/, andDhsp/p-CAG-cre/Esr1-positive
mice after 4-OHT administration resulting from a breeding according to the scheme in B and C of Fig. 1. A, bodyweight of animals after 4-OHT-mediated
knock-out in vivo at the indicated time points. Red arrow indicates duration of 4-OHT treatment. B, Kaplan-Meier plot showing overall survival of mice after
4-OHT-mediated knock-out in vivo at the indicated time points. Red arrow indicates duration of 4-OHT treatment. C, two-dimensionalWestern blot for eIF-5A1
after 4-OHT treatment in vivo. Heart and spleen were isolated from mice showing more than 20% weight loss. Colored arrows in the representative blots
correspond to the different eIF-5A1 forms as outlined in the schematic plot on the left: black fully hypusinated Lys50, pH 5.2; red unmodified Lys50, pH 5.1;
blue unmodified Lys50 plus acetylated Lys47, pH 5.0.D, quantitative real time PCR assessing themRNA expression status ofDhs, Dohh, and eIF-5A1 in several
tissues after 4-OHT treatment in vivo expressed relative to the housekeeping gene 18S rRNA. Organs were isolated from animals showing more than 20%
weight loss. E, comprehensive histopathological analysis of variousmouse organs after 4-OHT-mediated knock-out in vivo. Organswere isolated from animals
showingmore than 20%weight loss. Staining withmethylene blue or H&E showed reduced bonemarrow cellularity (4/4 animals) and an impaired cellularity
of the red pulpa in the spleen (4/4 animals), respectively, in Dhs-deficient animals. Turnbull staining unveiled enrichment of ferrous iron in the kidney of
Dhs-deficient mice (3/4 animals). Epithelium of the intestine was severely damaged in Dhs-deficient animals as demonstrated by H&E (1/4 animals). Signifi-
cances were calculated using the unpaired t test andmarkedwith an asterisk if significant (***, p	 0.001; **, p	 0.01; *, p	 0.05)., wild type allele, p, floxed
allele; n.d., not detectable. qPCR, quantitative PCR.
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mainly due to a reduction of all three cell lines in the bone
marrow and in the red pulpa of the spleen.Moreover, in two out
of four Dhs-deficient animals, the kidney showed enhanced
incorporation of ferrous iron (Fig. 4E); however, histological
examination revealed no obvious alteration in kidney tissue
architecture (data not shown). In addition, the epithelial struc-
tures of the intestine were markedly destroyed in one out of
four Dhsp/p animals. Thus, it can be assumed that loss of Dhs
confers lethality by induction of multiple phenotypic changes
particularly in highly proliferative tissues (bone marrow and
intestine) in adult mice.
Together, these data indicate that Dhs-mediated hypusina-
tion of eIF-5A1 is essential for embryonic development and is
mandatory to ensure viability of an adult organism.Moreover, a
potential positive feedback mechanism is activated protecting
heterozygous Dhs mice from gene dosage effects, underlining
the importance of the hypusine system for cellular integrity.
Dohh Is Equally Important for an Adult Organism but Con-
sequences of a Dohh Knock-out Are Less Pronounced Compared
with the Dhs Knock-out—The second step of hypusine modifi-
cation in eIF-5A1 was shown to be not essential in lower
eukaryotes like Saccharomyces cerevisiae (48). However, we
have shown recently that deletion ofDohh and subsequent loss
of hypusine modification induced an embryonic lethal pheno-
type in mice (33).
To investigate the role ofDohh in adultmice, we intercrossed
our previously described B6.DOHHtm2a/bal animals (33) with
the CAG/Cre-Esr1 mouse strain and used 4-OHT to induce
Dohh knock-out in 4–7-week-oldmice as described for theDhs
knock-out mouse model (Fig. 1, B and C). Notably, heterozy-
gous Dohhp/ animals behaved like wild type controls, but the
bodyweight ofDohhp/pmice stagnated, and animals finally died
1–5weeks after knock-out induction due to awasting condition
(median 20 days; Fig. 5, A and B). Although we observed an
expected decrease in Dohh mRNA in spleen and kidney from
those animals at a terminal stage (Fig. 5C), we could not detect
a consistent compensatory up-regulation of the hypusine sys-
tem as inDhs-deficientmice (Fig. 5D). As a consequence, loss of
Dohh resulted in a shift toward the unhypusinated eIF-5A1 pre-
cursor protein as seen in the spleen ofDohhp/p animals (Fig. 6A,
red arrow), even though hypusinated eIF-5A1 was still detect-
able (Fig. 6A, black arrow). In agreement with our recent in
vitro results (33) and in contrast to the ablation of Dhs, unhy-
pusinated and acetylated eIF-5A1 was not observed (Fig. 6A).
Although homozygous deletion ofDohhwas lethal in all ani-
mals, rigorous histopathological examinations of adult Dohh
knock-out mice (homozygote deletion of Dohh was induced in
sevenmice at the age of 5–7 weeks and in twomice at the age of
6–7 months) revealed no relevant recurrent tissue alterations
(Fig. 6, B–F) except histological signs for a tubular necrosis in
the kidney of one animal (Fig. 6B) and increased incorporation
of ferrous iron in the spleen of both analyzed adult (6–7months
old) animals (Fig. 6D). Furthermore, we have detected moder-
ate necrosis in the liver of two knock-out mice (group of 5–7
weeks oldmice) (Fig. 6E) andmoderate focal liver inflammation
in one knock-out animal (group of 6–7 month old mice) (Fig.
6F). Compared with the Dhs knock-out animals, bone marrow
was apparently not affected inDohh-deleted mice (Fig. 6C). All
other animals died without obvious cause, and no consistent
pathology could be identified.
FIGURE5.Dohh-mediatedhypusinationofeIF-5A1 isessential inadultmice.A–D,analysis of adultDohh/,Dohhp/, andDohhp/p-CAG-cre/Esr1-positive
mice after 4-OHT administration resulting from a breeding according to the scheme in Fig. 1, B and C. A, bodyweight of mice after 4-OHT-mediated knock-out
in vivo at the indicated time points. Red arrow indicates duration of 4-OHT treatment. B, Kaplan-Meier plot showing overall survival of mice after 4-OHT-
mediated knock-out in vivo at the indicated time points. Red arrow indicates duration of 4-OHT treatment. C and D, real time PCR assessing the mRNA
expression status ofDohh and eIF-5A1 in spleen and kidney after 4-OHT treatment in vivo expressed relative to the housekeeping gene 18S rRNA. Organswere
isolated from animals showing more than 20% weight loss. qPCR, quantitative PCR.
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Together with the observation that an early general knock-
out of Dohh is embryonically lethal as published by our group
recently (33), we conclude here that Dohh is equally as impor-
tant for early embryonicdevelopment andadult organismsasDhs,
yet the lethalphenotypeofDohh-deficient animals seems tobe less
pronounced. However, it must be pointed out that the exact rea-
son for the observed lethal phenotype has to be elucidated.
eIF-5A Is Also Localized in the Nucleus after Deletion of Dhs
or Dohh—Because modifications of eIF-5A1 influence its cellu-
lar localization (49, 50), the accumulation of different eIF-5A1
formsmay therefore account for the different phenotype of the
Dhs and theDohh knock-out. Although the knock-out ofDohh
causes an accumulation of unhypusinated eIF-5A1 precursor
(Fig. 6A, red arrow), Dhs deficiency provokes its additional
acetylation (Fig. 4C, blue arrow). Investigating the localization
of eIF-5A1 by immunofluorescence in aDhs- andDohh-depen-
dent setting in vitro, we found that the 4-OH-induced knock-
out of Dhs and Dohh leads to nuclear accumulation of eIF-5A1
(Fig. 7A). Because fully hypusinated eIF-5A1 was recently
shown to be located in the cytoplasm (where it regulates trans-
lation of specific proteins (11)), the observed nuclear eIF-5A in
the Dhs- and Dohh-deficient setting likely reflects the unhy-
pusinated (acetylated and nonacetylated) eIF-5A. Fig. 7B sum-
marizes an hypothesis explaining why eIF-5A1 is differently
modified in these scenarios. In a Dohh-deficient background,
DHS is constantly linked to eIF-5A1 due to themissing hydrox-
ylation of deoxyhypusine (Dhp50) and subsequently prevents
binding of acetyltransferases like HDAC6, SIRT2, p300, and
CBP (49, 51). In contrast,Dhs depletion prevents DOHH bind-
ing and further allows acetylation of eIF-5A1.
eIF-5A2 Is Not Essential for Normal Development and Steady
State Viability—As the general use of DHS and DOHH inhibi-
tors seems to require more refined analyses due to their essen-
tial role in higher eukaryotes, we reasoned whether eIF-5A2,
FIGURE6.LossofDohh revealshistological anomalies.A, two-dimensionalWesternblot for eIF-5A1 in spleen tissueafter 4-OHT treatment in vivo. Spleenwas
isolated frommice showingmore than 20%weight loss. Colored arrows in the representative blots correspond to the different eIF-5A1 forms as outlined in the
schematic plot in Fig. 4C.Black fully hypusinated Lys50, pH5.2; redunmodified Lys50, pH5.1.B,H&E stainingof kidney sections after 4-OHT induction in vivo
unveiled tubular necrosis in one of the Dohh-deficient mice (1/4 animals; red arrow). Organs were isolated from animals showingmore than 20%weight loss.
C,methylene blue staining revealed no overt change in cellular composition of the bonemarrow.D, histological analysis of the spleen using H&E staining did
not show any major difference. Turnbull staining unveiled enrichment in ferrous iron in Dohh-deficient mice (2/2 animals). E and F, H&E, Ki67, and caspase-3
staining of liver tissue compared with control in 5–7 weeks (E) and 6–7-month-old mice (F). Red arrow indicates liver necrosis, and green arrow indicates focal
inflammation.
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which is only expressed in few tissues of the body, but highly
abundant in cells of various tumor types, might represent a
better target for therapy. To address this question and to inves-
tigate the effects of eIF-5A2 deficiency in development and in
adult mice, we generated eIF-5A2 conditional knock-out mice
(B6.eIF5A2tm2a(EUCOMM)wtsi) (Fig. 8, A and B) and intercrossed
them with the CMV-Cre-deleter strain to induce an early gen-
eral knock-out (Fig. 1B). In contrast toDhs- andDohh-deficient
animals, both heterozygous eIF-5A2/ and homozygous eIF5-
A2/mice were viable (Fig. 9, A and B) and did not show any
abnormalities regarding body weight (data not shown) or sur-
vival over the indicated time period. Expression of eIF-5A2 is
thought to be limited to a few human tissues like lung, brain,
testis, or prostate (52). Quantitative PCR revealed a comparable
expression pattern in mouse tissues (Fig. 9C). As expected, eIF-
5A2 mRNA and protein are not detectable in testis and brain
tissue of eIF5-A2/mice (Fig. 9,D and E), indicating the func-
tional and successful knock-out. Moreover and in contrast to a
loss of DHS, a consistent compensatory overexpression of the
hypusine modification system was not detectable in eIF5-
A2/ mice (Fig. 9, F–H). Taken together, these data suggest
that loss of the eIF-5A2 isoform is not essential for embryonic
development or for steady state viability in an adult organism
because eIF-5A2 knock-out mice are viable, fertile, and do not
show an obvious phenotype. Fig. 10 summarizes phenotypes
induced by deletion of the hypusine modification systems.
eIF-5A Targets Are Organized in Highly Connected Protein-
Protein Interaction Networks—It was recently shown that fully
hypusinated eIF-5A1 is a sequence-specific elongation factor,
regulating the translation of proteins containing consecutive
prolines in the form of repetitive PPP (Pro-Pro-Pro) and/or
PPG (Pro-Pro-Gly) sequence units (11). Translation of proteins
working together in complexes is regulated in a “proportional
synthesis strategy” to provide the cell with the correct stoichio-
metric amounts for each member of the protein complex (53).
Based on these observations, we hypothesize that eIF-5A in
being a sequence-specific elongation factor might regulate the
optimal translation of PPP and PPG repeat-rich protein com-
plexes and that the observed phenotype after homozygous dele-
tion of Dhs or Dohh is based on disruption of those complexes.
Bioinformatic network analysis using STRING database and
the Cytoscape software platform with the aim to find network
clusters and essential proteins (hubs) was performed for yeast
and mouse genes expressing PPP or PPG units. To reduce the
complexity of the networks and to focus on proteins with long
consecutive proline sequences, we analyzed genes with more
than 1 PPP or PPGunit. The exact number of proteins that have
been used for network construction and number of nodes in the
networks are summarized in Table 2. As depicted in Figs. 11
and 12 PPP and PPG repeat-rich proteins are organized in net-
works with a considerable variance in the structure of the net-
works between both species. We exploited three fundamental
network parameters (clustering coefficient, average degree, and
network heterogeneity) to determine the network interconnec-
tivity (Table 2). Together, the global networks formurine genes
show a higher degree of interconnectivity. The average number
of neighbors (average degree) and the network heterogeneity
have shown higher values for themurine interactome. Interest-
ingly, yeast PPP-rich proteins form a highly connected network
with higher clustering coefficients than murine PPP-rich pro-
teins. Furthermore, detailed information for each node inside
the networks is available in supplemental Tables 1–4.
FIGURE 7. Knockdown of the hypusine modification enzymes affect localization and post-translational modification of eIF-5A1. A, immunofluores-
cence for endogenous eIF-5A1 in a Dhs or Dohh-deficient cellular background, respectively. Upper panels depict eIF-5A1 fluorescence alone; the lower panels
show the overlay of the eIF-5A1 signal (green) and the Hoechst 33342 nuclear DNA stain (blue). Primary MEFs from Dhsp/p;CAG-cre/Esr1 mice (left) and
immortalized MEFs (3T3) from Dohhp/p;CAG-cre/Esr1 animals (right) were treated with or without 4-OHT (100 nM; 7 days) in vitro to induce the respective
knock-out. Red arrows indicate nuclear accumulation of eIF-5A1. B, predicted model explaining how loss of Dhs and Dohh could influence eIF-5A1’s
modification.
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Identification of Protein Complexes and Biological Processes
in Proline Repeat-rich Proteins—To detect densely connected
subnetworks (clusters) potentially representing biological mod-
ules or protein complexes, we performedMCODE cluster anal-
ysis for yeast and murine PPP- or PPG-rich networks. This
resulted in a higher number of protein clusters forMusmuscu-
lus as compared with S. cerevisiae (Figs. 11 and 12), further
supporting the higher complexity of proline repeat-rich proteins
inmulticellular eukaryotes comparedwith yeast.We identified 28
and21clusters forPPP-andPPG-rich formurineproteins, respec-
tively. InS. cerevisiae,MCODEanalysis revealed fourandoneclus-
ters for PPP-rich and PPG-rich proteins, respectively. Detailed
information about the proteins forming these clusters is available
in supplemental Tables 1–4. To predict the biological functional-
ityof theclusters,weusedBinGOtodetermineenrichedbiological
processes.Highest scoring gene ontology (GO) terms are depicted
inFigs. 11 and12 for eachcluster. Strikingly, the functional activity
of these clusters partially overlapped between S. cerevisiae andM.
musculus. These includebiological processes involved in cytoskel-
etal organization and regulation, mRNA metabolism and pro-
cessing, as well as regulation of transcription. However, GO terms
associated with cellular differentiation, chromatin modification,
and DNA replication appeared exclusively in protein clusters
extracted fromM. musculus (Fig. 12), pointing further to special-
ized function of proline repeat-rich proteins in multicellular
eukaryotes.
Identification of Highly Connected Network Hubs—Given
that the most connected proteins in the network are the most
important for cellular survival (54), we used betweenness cen-
trality analysis to identify those network hubs for murine
FIGURE 8. Generation of a conditional eIF-5A2 knock-out mouse strain using an ES cell clone harboring a targeted mutation of the eIF-5A2 gene. A,
schematic representation of the knock-out strategy for achieving a conditional knock-out of the eIF-5A2 gene. The two exons designed for deletion are
depicted in a lighter color. Note that this regionencodes the translational start point and the critical hypusinemodification residueLys50. The targetedmutation
of the eIF-5A2 gene consists of a lacZ reporter cassette (SA, splice acceptor; IRES, internal ribosome entry site; lacZ, -galactosidase gene; pA, polyadenylation
signal), a neomycin-selection cassette (PAct, eukaryotic -actin promotor; neo
R, neomycin resistance gene), three loxP and two FRT sites. B, genotyping
strategy for Cre-mediated knock-out of the eIF-5A2 gene. Mice harboring the floxed eIF-5A2 gene were mated to Cre-deleter mice (B6.C-Tg(CMV-cre)1Cgn/J
strain). Usage of three oligonucleotides (eIF-5A2-3-arm, eIF-5A2-5-arm, and eIF-5A2-rev) allows detection of all possible alleles (, p, green arrow), including
the deleted allele (, red arrow), which is achieved by Cre-mediated recombination.
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PPP- or PPG-rich proteins, respectively. Betweenness central-
ity describes the level of control that one node exerts over the
interaction of other nodes in a network (55). Information about
the betweenness centrality score, for each protein in the global
networks for murine PPP- or PPG-rich proteins is available in
supplemental Tables 3 and 4. The 10 highest scoring proteins
are listed in Table 3. Furthermore, we performed a literature
search for known phenotypes associated with a knockdown of
these proteins inM. musculus (Table 3). These data suggested
that the observed phenotypes in Dhs and Dohh knock-out ani-
mals might be based on dysregulated translation of these pro-
teins after inhibition of the hypusine modification.
Discussion
The highly specific and conserved post-translational
hypusine modification system has a crucial function in trans-
lation regulation (9, 11), and aberrant activation or inhibition is
implicated in disparate disorders like cancer and infectious dis-
eases. Notably, hypusine modification of eIF-5A displays an
attractive platform for therapeutic intervention. First proof-of-
FIGURE 9. eIF-5A2 knock-out mice are viable and fertile. A, offspring analysis of the indicated breedings. B, Kaplan-Meier plot showing overall survival of
mice at the indicated time points after birth. C,mRNA levels of eIF-5A2 in different tissues of wild typemice as assessed by quantitative real time PCR using the
Tissue Scan qPCR Array MDRT101 (OriGene Technologies, Rockville, MD). Values were normalized to the expression of the housekeeping gene Gapdh and
depicted as fold changes with bonemarrow as the reference. D,mRNA status of eIF-5A2 in different organs of mice as assessed by quantitative real time PCR.
Expression values were plotted relative to the expression of the housekeeping gene 18S. E, protein expression of eIF-5A2 in testis and brain of eIF-5A2/
animals (n  2) and eIF-5A2/ mice (n  1) assessed by Western blot. eIF-5A1 expression served as a loading control. Organs were isolated from 7- to
10-month-old animals. F–H,mRNA status of eIF-5A1 as well as Dhs and Dohh in different organs of mice as assessed by quantitative real time PCR. Expression
values were plotted relative to the expression of the housekeeping gene 18S. Significances were calculated using the unpaired t test and marked with an
asterisk if significant (**, p	 0.001; *, p	 0.05). n.d., not detectable.
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principle studies have already shown promising results in that
direction (17, 56–58). However, this modification occurs in all
eukaryotic cells and has been shown to be essential for prolif-
eration of lower eukaryotes and mammalian cell lines (59). As
these data have beenmostly generated in yeast and in vitro, they
do not entirely reflect the in vivo situation in mammals. Not
surprisingly, there are concerns about whether such a crucial
modification can be safely targeted by drugs. From a clinical
point of view, further preclinical studies analyzing the biologi-
cal relevance of hypusinated eIF-5A are needed to evaluate the
hypusine axis as a drug target and to predict possible side
effects. The well known observation that 
20–30% of all new
therapeutic strategies fail in early clinical trials due to unex-
pected safety concerns clearly emphasizes that need (60).
Given that mouse models represent an appropriate tool to
predict possible side effects (61), we generated several condi-
tional knock-outmousemodels and here present the first com-
prehensive analysis of the biological consequences of the inhi-
bition of the hypusine system in adult mammals (summarized
in Fig. 10). Based onour results, we propose that particularly the
isoform eIF-5A2 represents a promising target for the treat-
ment of malignant tumors. In contrast, inhibition of the
hypusine-mediating enzymes (i.e. DHS and DOHH) seems to
have a smaller therapeutic index but nevertheless is tolerated
up to the level of haploinsufficiency. Therefore, they might be
targeted without relevant side effects in a pathological condi-
tion where cells depend on an increased rate of hypusine mod-
ification, as compared with normal cells.
Of note, we observed drastic effects upon a complete deletion
of eitherDhs orDohh. This is in line with a number of previous
observations, indicating that proliferation of eukaryotic cells
depends on accurate modification of eIF-5A1. One possible
explanation for the strong embryonic and adult phenotype
observed after deletion of Dhs and Dohh is that insufficient
hypusine modification of eIF-5A1 affects the correct transla-
tion of a huge number of proline repeat-rich proteins on the
level of single proteins and in terms of protein complexes. We
have shown here that murine proline repeat-rich proteins are
organized in networks with an increasing connectivity and
complexity inmulticellular eukaryotes compared with yeast. In
fact, recent data suggest that control of phenotypes is partially
regulated by multiprotein complexes rather than by single
genes (62, 63) and that protein complexes can be used to predict
phenotypic effects (64). We believe that disruption of these
complexes causes at least some of the knock-out phenotypes
described in this study. Differences in biological processes
enriched in protein complexes from M. musculus compared
with S. cerevisiaemay reflect the fact that in higher eukaryotes
the hypusine modification is involved in more complex cellular
functions and that both hypusine-modifying enzymes are
essential. In addition, centrality analysis of global murine net-
works revealed highly connected hubs (single highly connected
proteins) in the networks with crucial biological function for
development and viability. Literature analysis uncovers that a
single knock-out of most of the 10 highest scoring network
hubs leads to embryonic lethality in mice caused by diverse
defects (Table 3). Strikingly, dysregulation of each of the top
three proteins (Abl1, Crebbp, and Notch1) is associated with
defects in hematopoiesis (65–67). This meets our observation
of reduced cellularity in bone marrow and spleen after Dhs
depletion, indicating a severe defect in hematopoiesis as a con-
sequence of reduced hypusine modification. Together, the
observed phenotypes of Dhs and Dohh knock-out animals can
be interpreted as a synergistic effect of functional loss of single
essential proteins as well as multiprotein complexes due to
inhibition of the hypusine modification of eIF-5A. Further in
vitro and in vivo studies are needed to prove the functional
relevance of these bioinformatic-driven results. Furthermore,
becauseDHS andDOHHmight have other cellular targets than
eIF-5A, we cannot entirely exclude hypusine-independent
effects after deletion of Dhs and Dohh. Studies using mutated
hypusine-deficient eIF-5A (eIF-5A-K50mutant) will be needed
to further address this question.
Interestingly, the knock-out ofDohh, although lethal, exerted a
lower phenotype penetrance compared with the depletion of
Dhs, most likely because of the different modification states of
the resulting nonhypusinated eIF-5A1. In contrast to fully
hypusinated eIF-5A1, which is localized in the cytoplasmwhere
it regulates translation of specific proteins (11), the observed
unhypusinated acetylated and nonacetylated eIF-5A forms in
the Dhs- and Dohh-deficient setting, respectively, seem to be
located in the nucleus. Therefore, we assume that the pheno-
typical differences in Dhs and Dohh knock-out animals are
caused by yet unknown distinct nuclear functions of the acety-
FIGURE10.Summaryofobservedphenotypesaftergeneticmanipulation
of the hypusine modification system.Whereas a heterozygous knock-out
of any of the genes of the hypusine modification system does not affect the
viability of mice, a homozygous depletion of Dhs, Dohh, or eIF-5A1 causes
lethality in embryonic and adult mice with different penetrance. In contrast,
the cancer-associated isoform eIF-5A2 is dispensable for normal develop-
ment and viability.
TABLE 2
PPPandPPGrepeat-richproteins showingdifferentnetwork topology
in yeast andmouse
Overview of network parameters for protein-protein interaction networks of
murine and yeast proteins containing1 PPP or1 PPG units.
Network parameters
S. cerevisiae M. musculus
>1 PPP
unit
>1 PPG
unit
>1 PPP
unit
>1 PPG
unit
No. of proteinsa used for network
construction in STRING
76 14 1523 913
No. of nodes 70 11 1256 710
Clustering coefficient 0.392 0.136 0.238 0.251
Average no. of neighbors (average
degree)
7.0 2 11.1 9.5
Network heterogeneity 0.87 0.43 1.28 1.32
a Data were extracted from Ref. 35.
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lated and the nonacetylated unhypusinated eIF-5A1 precur-
sor. This observation points to modification-dependent and
translation-independent functions of the nonhypusinated eIF-
5A as it has been demonstrated for other translational factors or
ribosomal proteins (68, 69). However, the molecular functions
of the differentlymodified nonhypusinated eIF-5A1 forms have
to be elucidated. As current studies highlight that eIF-5A2 has
additional transcriptional activity (24), it can be assumed that
eIF-5A1 might have similar nuclear activity, which is responsi-
ble for its strong phenotype.
It is common knowledge that tumor cells accelerate their
translational activity to adapt to the increasing cellular
demands (2). Accordingly, previous work unveiled that the
hypusine modification system is frequently overexpressed in
cancer tissue (16, 17, 70), supporting the hypothesis that eIF-5A
facilitates translation of genes with tumor promoting activity as
described for other translation factors (71). Indeed, certain
oncogenes like c-abl contain polyproline stretches and should
therefore be translationally regulated by eIF-5A1. Furthermore,
our studies on glioblastoma cell lines have shown a higher sen-
sitivity of tumor cells against the inhibition of hypusine synthe-
sis compared with normal human astrocytes (16), suggesting
that certain malignant cells depend on an activated hypusine-
dependent translation that is above the activation level in nor-
mal cells. An intriguing observation made by using another
tumor model is that haploinsufficiency of ribosomal proteins
attenuates Myc-dependent malignant transformation without
affecting normal cells (72). This clearly highlights the depen-
dence of tumor cells on elevated translational activity. There-
fore, we propose that a pharmacological inhibition of the
hypusine-modifying enzymes below a level that is required for
tumor cell proliferation and disease progression might repre-
sent a reliable therapeutic intervention. Interestingly, the con-
cept of submaximal inhibition of hypusine synthesis has been
suggested recently for inflammatory diseases (44). However,
further studies to define the correct therapeutic index are
needed to prevent devastating effects on normal homeostasis.
Given the less pronounced phenotype of DOHH depletion, an
inhibition of the second step of hypusine modification might
represent the preferential target. In that regard, recent studies
FIGURE11.PPP- andPPG-richproteins form functional networks in yeast. STRING-network analysis for yeast (S. cerevisiae) genes encoding1PPPunits (A)
or1 PPG units (B). The complete protein-protein interaction networks are depicted in the center of A and B, respectively. Closely connected clusters were
directly extracted fromeachnetworkusing theMCODEalgorithm. Thehighest scoring clusters are representedaround thewholenetworks for genesencoding
1PPPunits (A) or1PPGunits (B). For each cluster, thehighest significantGObiological process basedonBinGOanalysis is indicated. Additional information
for complete networks and for all clusters is available in supplemental Tables 1 and 2.
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have demonstrated antiproliferative effects of DOHH inhibi-
tion in cancer cells (17, 70, 73).
In contrast to eIF-5A1, the expression of eIF-5A2 is limited to
tissue such as testis and few parts of the adult brain (52), but it is
highly abundant in cancers such as ovarian, lung, and mela-
noma (74–76). The eIF-5A2 gene is located on 3q26, a chromo-
somal region that is frequently amplified in cancer. Moreover,
the expression of eIF-5A2 in those entities correlates with sur-
vival (77, 78), disease stage, aswell asmetastasis (79), suggesting
that eIF-5A2 function is crucial for tumor development and
maintenance but not for normal tissue homeostasis. As eIF-
5A2 shares almost 84% homology with eIF-5A1, it can be spec-
ulated that eIF-5A2 is also implicated in translation elongation
and is responsible for the selective transport and translation of
specific mRNA subsets. This is supported by the observation
that eIF-5A2 is detectable in the riboproteome of prostate can-
cer cells compared with normal prostate cells (80).
However, although eIF-5A1 was shown to preferentially reg-
ulate the translation of proline-rich proteins (11), the spectrum
may be different for eIF-5A2. Furthermore, there are data that
propose that eIF-5A2 might also control transcriptional pro-
cesses in the nucleus, yet more studies are necessary to address
this question (24). In this regard, Zender and et al. (21) have
shown that nuclear eIF-5A2 exerts oncogenic activity. There-
FIGURE12.MurinePPP-andPPG-richproteinsareorganized inhighly interconnectednetworks.STRING-network analysis formurine (M.musculus) genes
encoding1 PPP units (A) or1 PPG units (B). The complete protein-protein interaction networks are depicted in the center of A and B, respectively. Closely
connected clusters were directly extracted from each network using theMCODE algorithm. The 10 highest scoring clusters are represented around thewhole
networks for genes encoding1 PPP units (A) or1 PPG units (B). For each cluster the highest significant GO biological process based on BinGO analysis is
indicated. Additional information for complete networks and for all clusters is available in supplemental Tables 3 and 4.
TABLE 3
Summary of the 10 highest connected proteins (hubs) in networks from murine proteins containing >1 PPP or >1 PPG units and known
knockout phenotype of the genes found in the literature
Gene
name Knock-out phenotype
M. musculus
1 PPP unit
Abl1 Neonatal lethality (
75%); thymic and splenic atrophy, T and B cell lymphopenia (65)
Crebbp Embryonic lethality (E9–10.5); defects in hemopoiesis, blood vessel formation, and neural tube closure (66)
Notch1 Embryonic lethality (before E11.5) (87), neonatally induced KO: growth retardation, defect in thymocyte development (67)
Ep300 Embryonic lethality (E9–11.5); defects in neurulation, cell proliferation, and heart development (88)
Abl2 Viable; no hematopoietic abnormalities, reduced litter frequency, behavioral phenotypes (89)
Erbb2 Embryonic lethality (E10.5); defects in cardiac and neural development (90)
Ptpn23 Embryonic lethality (E9.5) (91)
Erbb4 Embryonic lethality (E11); cardiac defects, alterations in hindbrain development (92)
Jund Viable; reduced postnatal growth, defects in male reproduction (93)
Smarca4 Embryonic lethality (before E6.5) (94)
M. musculus
1 PPG unit
Abl1 Neonatal lethality (
75%); thymic and splenic atrophy, T and B cell lymphopenia (65)
Notch1 Embryonic lethality (before E11.5) (87), neonatally induced KO: growth retardation, defect in thymocyte development (67)
Jund Viable; reduced postnatal growth, defects in male reproduction (93)
Mapk7 Embryonic lethality (E9.5–10.5); abnormal embryonic cardiac and vascular development (95)
Ep300 Embryonic lethality (E9–11.5); defects in neurulation, cell proliferation, and heart development (88)
Dhx8 No information for knock-out mice available
Crebbp Embryonic lethality (E9–10.5); defects in hemopoiesis, blood vessel formation, and neural tube closure (66)
Cad No information for knock-out mice available
Smarca4 Embryonic lethality (before E6.5) (94)
Ptpn23 Embryonic lethality (E9.5) (91)
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fore, it is conceivable that the two isoforms differ in their func-
tion. This hypothesis is supported by our previous observation
that the protein interaction networks of both isoforms show
isoform-specific protein-protein interaction patterns (81).
Although eIF-5A1 seems to control basic cellular processes,
eIF-5A2 is rather involved in disease regulation and is essential
during tumorigenesis, making it more attractive as a therapeu-
tic target. Encouraging reports in the direction of isoform-spe-
cific drug targeting have been described for other essential
genes. Muller et al. (82) introduced the concept of collateral
vulnerability for the inhibition of enolase 2 in glioblastoma
cells. Although targeting enolase 2 in tumor cells inhibited cell
growth, normal astrocytes were protected by the expression of
enolase 1. Other promising examples for isoform-specific
tumor targeting have been demonstrated for pyruvate kinaseM
(83) and phosphoinositide 3-kinase (84).
Indeed, recent data from in vitro studies support the hypoth-
esis that eIF-5A2 has oncogenic potential (21, 22). In particular,
inhibition of eIF-5A2 by shRNA blocked invasion in a mela-
noma cell line and inhibited growth of ovarian cancer (22, 76).
Moreover, foci formation capacity was markedly reduced in
liver cancer cells transfectedwith eIF-5A2 shRNA (21). Intrigu-
ingly, in terms of oncogenic activity, the presence of eIF-5A1 in
these cancer cells could not compensate for the loss of the sec-
ond isoform. This leads to the assumption that certain tumor
cells are dependent on functional eIF-5A2, and the specific
interference with eIF-5A2 activity displays an effective strategy
to block proliferation and invasion in eIF-5A2-overexpressing
cancers. Remarkably, we found that knock-out of eIF-5A2 is not
lethal in adult mice and that animals do not show any conspic-
uous phenotype, suggesting that the expected toxic effects may
be quite low in normal tissues after eIF-5A2 interference. This
finding differs from the data fromCaenorhabditis elegans stud-
ies where phenotypical alterations after deletion of both iso-
forms were shown (85). Nevertheless, the exact role of eIF-5A2
still needs to be elucidated. This research will be of great inter-
est to address eIF-5A2’s detailed molecular function and may
enable therapeutic targeting of downstreammolecules or path-
ways in eIF-5A2-dependent tumor entities.
Together, our knock-out mouse models have revealed
important aspects of the biology of the hypusine modification
system inmammals and constitute a useful resource for further
investigation into the molecular function of the hypusine mod-
ification under normal and pathological conditions. Further-
more, our data suggest that the hypusine biosynthesis can be
harnessed for therapeutic intervention. Evenmore intriguing is
the observation that the cancer-related isoform eIF-5A2 is not
crucial for normal homeostasis in mammals. Therefore, we
propose that specific inhibitors of eIF-5A2 will exhibit selective
toxicity toward malignant cells, making them promising thera-
peutic targets in the treatment of eIF-5A2-dependent tumors.
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